Gardasil and Cervarix share innovation prize
September 25, 2008Sales and Marketing Cancer, Gardasil, prix galien, vaccines
Rival vaccine products that will prevent thousands of women developing cervical cancer have been declared joint winners of the prestigious …
Brown to scrap prescription costs for cancer patients
September 24, 2008Cancer, NHS
Patients suffering from cancer won't have to pay for prescriptions after April next year under new government plans. Prime minister …
Sanofi seals Zentiva deal with improved offer
September 23, 2008Sales and Marketing MA, Sanofi, generics
Sanofi-Aventis' acquisition of Czech generics firm Zentiva is back on, after the pharma company increased its offer by nearly 10%. …
Pharma and the High Street health shop
September 23, 2008Sales and Marketing industry relations, pharmacy
The April publication of the long-awaited pharmacy White Paper – 'Building on Strengths, Delivering the Future' – spells exciting times …
Latest news from Datamonitor
September 23, 2008biotech
Monoclonal antibody sales to almost double by 2013In 2007, total global monoclonal antibody sales reached $26 billion and are forecast …
Giuliani to argue Ranbaxy’s case in US
September 18, 2008Sales and Marketing US, generics
Indian generics firm Ranbaxy has hired former New York mayor Rudolf Giuliani to help reverse an FDA block on imports …
Once-daily Seroquel launched
September 18, 2008Sales and Marketing AZ, psych
AstraZeneca has launched a once-daily version of Seroquel in the UK. The drug is used to treat schizophrenia and manic …
Ban on ‘top-up’ payments for drugs not working
September 18, 2008Sales and Marketing NHS, par
The King's Fund says the current ban on NHS patients paying privately for 'top-up' drugs is not working. The Department …
Working Life: Amanda Moosa
September 18, 2008Business Services, Sales and Marketing Nycomed, Working Life, branding, careers, marketing, sales
How did you find your way into your current role?I came into things via the ‘traditional’ route. After my biochemistry …
The Pharmafocus Interview: Andrew Dillon
September 17, 2008Research and Development, Sales and Marketing NHS, NICE, hc
NICE's rejection of four new cancer drugs predictably provoked the ire of campaigners, again raising unfavourable comparisons with European uptake …
GSK seeks risk-sharing deal for Tyverb
September 17, 2008Sales and Marketing Cancer, GSK, NICE, par
GlaxoSmithKline has approached the government for a new pricing deal on its breast cancer drug Tyverb, which could make it …
PCTs told to explain how drug funding decisions are reached
September 17, 2008NHS, hc
The Department of Health has written to PCT chief executives requesting information on how they reach funding decisions on new …
GSK unveils new cancer unit
September 17, 2008Research and Development Cancer, GSK
GSK has unveiled a new integrated oncology R&D unit aimed at enhancing its presence in cancer care.The unit will be …
Amgen sells off two biotech products
September 16, 2008Research and Development biotech
Biotech pioneer Amgen has sold off two niche products to Biovitrum, along with the promotional rights to a third product, …
Latest news from Datamonitor
September 15, 2008Sales and Marketing NICE, rcc
UK watchdog's guidance knocks kidney cancer drugsThe UK's cost-effectiveness watchdog NICE has delivered another blow to the developers of targeted …
Lilly launches diabetes patient education programme
September 12, 2008Medical Communications, Sales and Marketing diabetes, patients
Lilly has launched an international diabetes education programme, the centrepiece of which is a tool for healthcare professionals to conduct …
Patient wins legal battle for Revlimid
September 12, 2008Sales and Marketing Cancer, Revlimid
A cancer patient has won access to cancer drug Revlimid in a court battle with his local PCT. West Sussex …
The potential and the perils of online recruitment
September 11, 2008Business Services careers, digi, recruitment
It's easy to be someone different on the internet – a recent conference on Second Life was attended by a …
Merck Serono takes lead role in antibody partnership
September 11, 2008Research and Development Merck Serono
Merck Serono has agreed to take on full responsibility for developing a promising antibody from its partner ZymoGenetics. The German …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
